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ause Left Ventricular
oncompaction With Subclinical Myopathy?
n their article, Vatta et al. (1) showed that dilative cardio-
yopathy (DCM) is associated with cypher (Z-band
lternatively-spliced PDZ-motif-protein) gene mutations in
xons 4, 6, and 10 in 6% of the cases. Additionally, mutant
ypher-gene-transfected myoblasts developed cytoskeletal dis-
rray (1). Their findings raise the following concerns: It is not
entioned which clinical and echocardiographic criteria for
CM were applied. Were patients with DCM due to coro-
ary heart disease also included, or did all patients have normal
oronary angiograms? It remains unclear according to which
riteria left ventricular hypertrabeculation/noncompaction
LVHT/NC) was diagnosed (2,3). It is not indicated whether
atients with DCM were consecutively or selectively included
nd how many centers recruited the patients during which
eriod. Did relatives of all 100 patients or only those of
ypher-gene mutation carriers undergo clinical cardiologic and
eurologic examination, creatine-kinase determination, and
enetic studies? How was cardiac affection defined? It is
nclear why patient II:1 (family 065) was classified as cardio-
ogically normal, although, according to their Table 3, no
chocardiographic examinations were performed. Further-
ore, the description of a “mildly dilated left ventricle” in
atient III:1 does not match Table 3, indicating that echocar-
iography was not carried out at all in this patient. Concerning
he authors’ speculations that mutations in the skeletal muscle
ypher-isoform may go along with fatigue and exercise intol-
rance, it would be interesting to know whether any of the
utation carriers complained about symptoms suggestive of a
euromuscular disorder. How do the authors explain that
ypher knock-out mice develop severe myopathy, whereas
umans with cypher-mutations were neurologically normal?
ormal clinical neurologic examination and normal creatine
inase, however, do not rule out myopathy. It is not clear
hether the skeletal muscle cypher-isoform was regularly
xpressed in the skeletal muscle. Did any of the patients
ndergo muscle biopsy? It appears as if the 200 control subjects
ad not undergone clinical cardiologic or neurologic investiga-
ions. Did any of these probands have DCM or LVHT/NC?
t remains unclear how mutations in exon 4 were exclusively
ssociated with LVHT/NC although the inclusion criterion
as DCM. Did the authors find mutation carriers without
linical affection? It is not mentioned how many of the patients
ith cypher mutations also had LVHT/NC. Concerning their
able 3, the title is misleading because not all patients had
ypher-mutations. It also is not explained from which mea-
urements the standard deviation was calculated. Were patients
epeatedly investigated or does it derive from a non-described
ontrol group? Figure 1B erroneously shows a 352M instead ofI352M mutation. The authors do not mention that eVHT/NC may be also associated with mutations in the
MPK, DMD, AMPD1, and mitochondrial gene(s) (4–6).
verall, the study lacks proper characterization of the pheno-
ype and control group. Criteria for cardiac affection are
mbiguous. Although the study nicely shows cypher-mutations
o be associated with LVHT/NC, the prevalence of this
ssociation remains uncertain. To further clarify the pathoge-
etic background of LVHT/NC, we suggest that patients with
VHT/NC should undergo thorough investigation of the
keletal muscle in the light of previous findings, according to
hich LVHT/NC is associated with myopathies in up to
our-fifths of these patients (3).
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e would like to thank Drs. Finsterer and Stollberger for
heir comments. Our study (1) was performed on patients
ith left ventricular (LV) dysfunction associated with classic
ilated cardiomyopathy (DCM) or left ventricular non-
ompaction (LVNC). All patients had standard echocardio-
raphic evaluations and/or cardiac magnetic resonance im-
ging with selected cases having cardiac catheterization and
ngiography. Because the vast majority of patients evaluated
ither had classic autosomal-dominant inheritance and/or
ere of a young age, coronary angiography was not indi-
ated in many of these subjects. In addition, no patient had
vidence of regional wall abnormalities on echocardiogra-
